Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010
The article reveals that Black men in England face significantly higher lifetime risks of prostate cancer diagnosis and mortality compared to White and Asian men, with the highest diagnosis and death rates among Black men, while mortality rates post-diagnosis are similar across ethnic groups.
Equality, inclusivity, and holistic care of prostate cancer
Siva Tharshini Ramalingam, Cardio-Oncology Specialty Doctor at the Royal Brompton Hospital in London, shares insights on equality, inclusivity, and holistic care of prostate cancer.
Reasonable adjustments for people with Learning Disabilities
Serena Jones, Learning Disability & Autism Acute Liaison Nurse at the Liverpool University Hospitals NHS Foundation Trust, explains which reasonable adjustments to action for patients with learning disabilities when visit them.
Sexual Wellbeing: A Practical Guide
Lorraine Grover, Psychosexual Nurse Specialist at the London Clinic, provides you with a practical guide to support your patients on sexual wellbeing.
The importance of real-world data in prostate cancer
Natalia Norori, Data & Evidence Manager at Prostate Cancer UK, helps us understand the importance of real- world data in prostate cancer.
Considerations for transgender and gender diverse patients with prostate cancer
Stewarts O’Callagham, CEO at OUTpatients, Alison Berner, Academic Clinical Lecturer at the Barts Cancer Institute , and Lloyd Young, patient with lived experience, share their considerations on the LGBTQI+ prostate cancer patients.
Variation in harms and benefits of prostate-specific antigen screening for prostate cancer by socio-clinical risk factors: A rapid review
The article reviews PSA screening for prostate cancer, showing it improves detection of low-grade cancers and reduces advanced cases, especially in men aged 50-55 and those with a family history, but its long-term impact on mortality and ethnic risk needs further research.
